Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Zealand Pharma - Transactions related to share buy-back program (week 33, 2026)
Company announcement No. 40 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 33, 2026) Copenhagen, Denmark, August 17, 2026 – Zealand Pharma A/S ('the Company' or “Zealand Pharma”) (Nasdaq: ZEAL)…
China's pharma contractors rally on pushback to US supply chain pressure
China's pharmaceutical contractors are showing financial resilience in the face of Washington's push to curb reliance on Chinese supply chains. Analysts said investors were bullish because the US government's recent measures to curb Beijing's rise…
Schott Pharma Stock Rises as Barclays Upgrades Rating on Growth Outlook
Schott Pharma shares climbed more than 4% in early Frankfurt trading after Barclays upgraded the pharmaceutical packaging company to Overweight, citing improving fundamentals and expectations for accelerating earnings growth. Barclays believes…
XPH vs PJP: Which Pharma ETF Offers Better Value
Invesco Pharmaceuticals ETF (PJP +0.59%) provides a concentrated, low-volatility approach to drug manufacturers, while the State Street SPDR S&P Pharmaceuticals ETF (XPH -0.87%) offers broader sector exposure at a significantly lower annual cost.
Sun Pharma gets favourable verdict in antitrust-litigation in U.S.
Sun Pharmaceutical Industries on Monday (August 17, 2026) said an appellate court in the United States has passed a judgment in favour of the company and its subsidiaries in the antitrust litigation, in the U.S., relating to a 2008 patent…
Challenge and opportunity in Ireland's regulatory pharma space
Viatris' Suzanne Keating discusses the changing face of pharma frameworks in Ireland and offers advice for young professionals “After finishing my university degree in chemistry in the 1990s, employment opportunities in Ireland were few and…
Pharma companies seek to block state expansion of discount drug program
(The Center Square) – Multiple drug makers in Illinois are challenging a state law that expands the scope of a federal program under Medicare, arguing Illinois doesn't have the authority to make changes to the program. The federal 340B…
USFDA closes inspection of Aurolife Pharma's facility in the US
The United States Food and Drug Administration (USFDA) has issued an Establishment Inspection Report (EIR) for Raleigh Plant, North Carolina, USA, owned by Aurolife Pharma LLC, a wholly owned arm of Aurobindo Pharma for manufacturing Inhalers…
TDs call on pharma company to work with HSE to give access to life-changing drug Skyclarys
FINE GAEL MEMBERS today met with the manufacturers of Skyclarys, a disease-modifying drug for the rare disease Friedreich's Ataxia. Pressure has been mounting on government leaders to intervene and reverse a HSE decision recommending against…
Indian Stock Market Declines: Crude Oil Spike, US Bond Yields, West Asia Tensions Impact Sentiment
Indian stock markets, including the Sensex and Nifty, opened lower as a significant jump in Brent crude oil prices above $91 per barrel, fuelled by escalating West Asia tensions and rising US bond yields, dampened investor sentiment. Indian…
Stock Markets decline in early trade as crude oil jumps to $91 per barrel
Market benchmark indices Sensex and Nifty declined in early trade on Tuesday (August 18, 2026) as elevated crude oil prices and rising tensions in West Asia weighed heavily on investors' sentiment. The 30-share BSE Sensex was down 278.32 points to…
Nifty, Sensex Decline: Crude Oil Prices, Geopolitical Tensions Impact Indian Markets
Indian benchmark indices, Nifty and Sensex, extended their losing streak for a fifth consecutive session, with rising crude oil prices and ongoing geopolitical tensions in West Asia weighing heavily on investor sentiment. The Sensex declined by…
Why drugs are becoming more expensive to develop
When it comes to the pharma industry, US President Donald Trump has repeatedly accused European governments of “free-riding” on American spending, arguing that the profits generated from the US market help fund drug research and…
dsm-firmenich Board of Directors proposes Richard Ridinger as new Chairman following Thomas Leysen's decision to retire
Ad hoc announcement pursuant to article 53 LR dsm-firmenich Board of Directors proposes Richard Ridinger as new Chairman following Thomas Leysen's decision to retire Kaiseraugst (Switzerland), Maastricht (Netherlands), August 18, 2026…
Insight Molecular Diagnostics (IMDX) Q2 2026 Earnings Call Transcript
Monday, Aug. 10, 2026 at 5:00 p.m. ET President and CEO - Josh Riggs Chief Science Officer - Ekke Schutz CFO - Andrea James Investor Relations - Gabrielle Woody Net Revenue -- $239,000 for the second quarter, primarily generated from laboratory…
Receive a Daily briefing on Pharma Industry News
Get Started